NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 332 filers reported holding NATERA INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,654,377 | -51.0% | 218,178 | -46.2% | 0.32% | -43.6% |
Q2 2023 | $19,720,390 | -49.8% | 405,269 | -42.7% | 0.57% | -50.7% |
Q1 2023 | $39,264,521 | +651.9% | 707,214 | +444.0% | 1.16% | +688.4% |
Q4 2022 | $5,222,100 | -0.7% | 130,000 | +8.3% | 0.15% | -3.9% |
Q3 2022 | $5,258,000 | -70.5% | 120,000 | -25.0% | 0.15% | -40.9% |
Q3 2021 | $17,830,000 | +3538.8% | 160,000 | +999.7% | 0.26% | +2490.0% |
Q4 2019 | $490,000 | +2.7% | 14,549 | 0.0% | 0.01% | -23.1% |
Q3 2019 | $477,000 | +19.0% | 14,549 | 0.0% | 0.01% | +44.4% |
Q2 2019 | $401,000 | -30.3% | 14,549 | -39.4% | 0.01% | -40.0% |
Q3 2018 | $575,000 | – | 24,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |